[Enteral nutrition for management of diabetic enteropathy: a case report].

several cases reported in the literature1,3,5--7 (in addition to our case) where 18FDG-PET (alone or combined with CT) was of value for the localization of occult ECS due to carcinoid tumor. Moreover, various studies have shown its value in detecting neuroendocrine tumors in general (secreting and non-secreting),8,9 mainly atypical ones (showing greater hypermetabolism).10 The development of new tracers for PET (Ga68-DOTApeptides such as DOTATOC, DOTANOC, and DOTATATE) that specifically bind to somatostatin receptors in neuroendocrine tumors (type 2, type 5 and, to a lesser extent, type 3) will represent a significant change in the monitoring of these tumors.11 The reason for this is that because of their greater spatial resolution (when PET and CT are combined), 5. Moraes AB, Taboada GF, Carneiro MP, Neto LV, Wildemberg LE, Madi K, et al. Utility of [(18)F] fluoro-2-deoxy-D-glucose positrón emission tomography in the localization of ectopic ACTH-secreting tumors tomography in the localization of ectopic ACTH-secreting tumors. Pituitary. 2009;12:380--3. 6. Biering H, Pirlich M, Bauditz J, Sandrock D, Lochs D, Gerl H. PET scan in occult ectopic ACTH syndrome: a useful tool? Clin Endocrinol (Oxf). 2003;59:402--6. 7. Markou A, Manning P, Kaya B, Datta S, Bomanji J, Conway G. [18F]fluoro-2-deoxy-d-glucose ([18F]FDG) positron emission tomography imaging of thymic carcinoid tumor presenting with recurrent Cushing’s syndrome. Eur J Endocrinol. 2005;152:521--5. 8. Boegerle S, Altehoefer C, Chanem N, Koehler C, Waller C, Scheruebl H, et al. Whole body 18 F dopa PET for detection of gastrointestinal carcinoid tumors. Radiology. nloaded from http://www.elsevier.es, day 19/06/2017. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited.